ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Masaryk Memorial Cancer Institute at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Masaryk Memorial Cancer Institute takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans cancer biomarkers and treatment across several tumour types. It examines testing for HER2 and other biomarkers in advanced stomach and oesophageal cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Masaryk Memorial Cancer Institute Brno, Czech Republic | |
Specialised cancer hospital and research institute in Brno, Czech Republic. | Poster Fri Oct 23 13:00–15:00 Electrochemical biochips for rapid detection of cancer biomarkers at the point of care Gastrointestinal cancersGynaecological cancersMelanoma & skin cancersSarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Primary prostatic seminoma: A systematic review of diagnostic features and treatment outcomes in the modern era Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Chair Sat Oct 24 18:30–20:00 ESMO Colloquium supported by Jazz Pharmaceuticals - Optimising the management of patients with advanced HER2+ gastroesophageal adenocarcinoma: ‘Testing’ the way to efficacy and safety Gastrointestinal cancersBiomarkers & precision oncology Talk Sat Oct 24 18:30–18:45 Presentation of a clinical case: Biology of HER2, PDL1 and biomarker testing Gastrointestinal cancersBiomarkers & precision oncology |
Find decision makers at Masaryk Memorial Cancer Institute
Tell us what you sell and we’ll find the people at Masaryk Memorial Cancer Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction